The effect of the Gly16Arg polymorphism of the β2-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity

被引:35
|
作者
Meirhaeghe, A
Luan, JA
Selberg-Franks, P
Hennings, S
Mitchell, J
Halsall, D
O'Rahilly, S
Wareham, NJ
机构
[1] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England
[2] Univ Cambridge, Dept Med, Cambridge CB2 2SR, England
[3] Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2SR, England
来源
关键词
D O I
10.1210/jc.86.12.5881
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The lipolytic effects of catecholamines are mediated through members of the beta (2)-adrenergic receptor (BAR-2) family. Previous studies have suggested that genetic variants in the BAR-2 gene may be associated with obesity in some populations. To our knowledge, no studies have directly examined the effects of this polymorphism on circulating nonesterified fatty acid (NEFA) levels. To explore this issue further, a cohort of 604 Caucasian individuals (aged 40-65 yr) was genotyped for a common polymorphism in the BAR-2 gene (Gly16Arg), and the relationships between genotype, body mass index (BMI), NEFA, and lipid levels were examined. Women bearing the Arg16 allele had higher BMI values (P < 0.01) than Gly16Gly women. Women carriers of the Arg16Arg genotype had lower fasting plasma NEFAs (P < 0.01) and greater suppression of NEFAs (P < 0.01) after an oral glucose load than women bearing the Gly16 allele. In multivariate analysis after adjustment for age, sex, and smoking status, the interaction between the BAR-2 genotype and BMI in determining fasting NEFA concentrations was statistically significant (P < 0.05). The availability of objective measures of total energy expenditure in this population permitted the further examination of interactions, particularly that between genotype and physical activity. In the population as a whole, after adjustment for confounding by age, smoking, and BMI, the effect of the Arg16Arg genotype on the suppression of NEFA levels was modified by,physical activity level (P for interaction <0.05). These data suggest the existence in this population of a gene-physical activity interaction on NEFA levels.
引用
收藏
页码:5881 / 5887
页数:7
相关论文
共 50 条
  • [31] Association of the Arg16Gly polymorphism of the beta-2-adrenergic receptor with psoriasis
    Ozkur, M
    Erbagci, Z
    Nacak, M
    Tuncel, A
    Gorucu, S
    Aynacioglu, AS
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2004, 35 (02) : 162 - 164
  • [32] Is Gly16Arg β2 Receptor Polymorphism Related to Impulse Oscillometry in a Real-Life Asthma Clinic Setting?
    Jabbal, Sunny
    Manoharan, Arvind
    Lipworth, Joseph
    Anderson, William
    Short, Philip
    Lipworth, Brian
    LUNG, 2016, 194 (02) : 267 - 271
  • [33] Arg16gly polymorphism of the β2-adrenergic receptor gene does not modulate clinical response to salmeterol in subjects with asthma regardless of race or ethnic subgroup
    Ortega, H.
    Yancey, S.
    Reilly, D.
    Sutton, L. B.
    Emmett, A.
    Anderson, W.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A8 - A8
  • [34] Association between β2-Adrenergic Receptor-16Arg/Gly Gene Polymorphism and Chronic Obstructive Pulmonary Disease Risk: Systematic Review and Meta-Analysis
    Wang, Wei
    Li, Ping
    Chen, Yifei
    Yang, Jiong
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2014, 43 (07) : 877 - 888
  • [35] Gln27Glu and Arg16Gly polymorphisms of the β2-adrenergic receptor gene are not associated with obesity in Japanese men
    Hayakawa, T
    Nagai, Y
    Kahara, T
    Yamashita, H
    Takamura, T
    Abe, T
    Nomura, G
    Kobayashi, K
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (09): : 1215 - 1218
  • [36] β2 adrenergic receptor gene Arg16Gly polymorphism is associated with therapeutic efficacy of benazepril on essential hypertension in Chinese
    Huang, G
    Xing, HX
    Hao, K
    Peng, SJ
    Wu, D
    Guang, WW
    Huang, AQ
    Hong, XM
    Wang, YP
    Feng, Y
    Zhang, Y
    Li, JP
    Chen, CZ
    Wang, GY
    Huo, Y
    Chen, DF
    Hou, YT
    Wang, XB
    Xu, X
    Niu, TH
    Xu, XP
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2004, 26 (06) : 581 - 592
  • [37] Beta-adrenergic receptor Gly16Arg variation: Effect on response to budesonide/formoterol or fluticasone propionate/salmeterol in asthma patients
    Ambrose, Helen
    Lawrance, Rachael
    Goldman, Mitchell
    CHEST, 2007, 132 (04) : 478S - 478S
  • [38] Ary16Gly polymorphism of the β2-adrenergic receptor gene does not modulate clinical response to salmeterol in subjects with asthma
    Bleecker, E. R.
    Nelson, H.
    Corren, J.
    Kraft, M.
    Yancey, S.
    Ortega, H.
    ReiIly, D.
    Emmett, A.
    Anderson, W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S143 - S143
  • [39] Genotype Gly/Gly of the Arg16Gly polymorphism of the β2-adrenergic receptor is associated with elevated fasting serum insulin concentrations, but not with acute insulin response to glucose, in type 2 diabetic patients
    Ikarashi, T
    Hanyu, O
    Maruyama, S
    Souda, S
    Kobayashi, C
    Abe, E
    Ukisu, J
    Naganuma, K
    Suzuki, A
    Toya, M
    Kaneko, S
    Suzuki, K
    Nakagawa, O
    Aizawa, Y
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 63 (01) : 11 - 18
  • [40] EFFECT OF GLY 16 ARG SINGLE NUCLEOTIDE POLYMORPHISM ON AGONIST BINDING TO BETA 2 ADRENERGIC RECEPTOR - A STRUCTURAL PHARMACOGENOMIC APPROACH
    George, Samuel Gideon P.
    Dhivya, K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (10): : 4064 - 4073